Free Trial

Exagen (XGN) SEC Filings & 10K Form

Exagen logo
$5.77 -0.19 (-3.19%)
Closing price 04:00 PM Eastern
Extended Trading
$5.68 -0.09 (-1.47%)
As of 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Exagen SEC Filings

DateFilerForm TypeView
05/20/2025
3:43 PM
Exagen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/12/2025
4:37 PM
Cowen Financial Products LLC (Filed by)
Exagen (Subject)
Form SCHEDULE 13G/A
05/05/2025
8:31 AM
Exagen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2025
7:01 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
5:17 AM
Exagen (Filer)
Form DEFA14A
04/30/2025
5:20 AM
Exagen (Filer)
Form ARS
04/30/2025
5:15 AM
Exagen (Filer)
Form DEF 14A
03/11/2025
8:21 AM
Exagen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
5:48 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:58 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4/A
02/25/2025
7:59 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:59 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:00 PM
Exagen (Subject)
NMSIC Co-Investment Fund, L.P. (Filed by)
Form SCHEDULE 13G/A
01/13/2025
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
4:00 PM
Exagen (Subject)
Hunt Holdings Limited Partnership (Filed by)
Form SC 13G/A
11/19/2024
6:24 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
5:32 PM
ABALLI JOHN (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:39 PM
Adawi Kamal (Reporting)
Exagen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:12 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
5:12 PM
Black Jeffrey G. (Reporting)
Exagen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2024
4:08 PM
Adawi Kamal (Reporting)
Exagen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:15 AM
Exagen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
7:00 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
4:20 PM
Exagen (Filer)
Form 8-K/A
08/02/2024
7:15 AM
Exagen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:XGN) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners